|
Overview
| Day 1 |
Day
2 | Day 3 | Download
Brochure | Breakout
Discussions
Pre-Conference Short Course
Tuesday, February 24
Current Commercial Considerations for
Cell-Based Therapies
Lee Buckler, Bed, LLB, Principal, Cell Therapy Group
Dawn Driscoll, Ph.D, M.B.A., Principal, DCi Biotech
PLENARY KEYNOTE SPEAKERS
 David Ewing Duncan,
Chief Correspondent, NPR Talk’s “Biotech Nation” and Best Selling
Author “Masterminds”
 Jay M. Tenenbaum, Ph.D., Chairman and Chief Scientist,
CollabRx, Inc.
 James A. Wells, Ph.D., Chair, Department
of Pharmaceutical Chemistry; Professor of Pharmaceutical Sciences,
Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology;
and Director of the Small Molecule Discovery Center, University of California, San Francisco
 Michael J. Yaszemski, Ph.D., M.D., Brigadier General, United States Air
Force Reserves, Professor, Orthopedic Surgery and Biomedical Engineering, Mayo
Clinic College of Medicine
Session Topics Include
The Stem Cell Niche
Controlling And Understanding Differentiation
Therapeutic Themes: Considerations For Cardiac Regeneration
Harnessing Cells For Regenerative Healing
Therapeutic Themes: iPS Cells and Personalized Medicine
NEW! Venture Capital and Emerging Company Forum
Address the topics central to the theme of regenerative medicine
Network with prominent researchers, clinicians, businessmen,
and regulators at the cutting edge of their respective fields
Develop strategies to enable the rapidly expanding therapeutic
potential of regenerative medicine
Overview
| Day 1 |
Day
2 | Day 3 | Download
Brochure | Breakout
Discussions
For more information, please contact Mary Ann Brown at:
Cambridge Healthtech Institute
250 First Avenue, Suite #300
Needham, MA 02494
Email: mabrown@healthtech.com
For sponsorship information, please contact:
Carol Dinerstein
Email: dinerstein@healthtech.com
Tel: 781-972-5471
|
2009 Final
Brochure Download
|
